Indication
Type 2E
1 clinical trial
1 product
Product
SRP-9003Clinical trial
A Single-Center, Open-Label, Systemic Gene Delivery Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9003 Administered by Systemic Infusion in Subjects With LGMD2E (β-Sarcoglycan Deficiency)Status: Active (not recruiting), Estimated PCD: 2027-02-14